$CLNV Clean Vision Corporation Launches Clean-Seas UK

New Post Public Reply Private Reply Replies (0) Message Board
louied91
214
$CLNV Clean Vision Corporation Launches Clean-Seas UK Bolstering Global Operations and Facilitating Green Bond Investment

https://www.accesswire.com/815794/clean-visio...investment

LOS ANGELES, CA / ACCESSWIRE / December 12, 2023 / Clean Vision Corporation (OTCQB:CLNV) ("Clean Vision" or the "Company" , a leader in innovative plastic recycling and clean fuel development, is proud to announce the establishment of our subsidiary, Clean-Seas Partners UK Limited ("CS-UK" . CS-UK was established for the purpose of launching the Company's currently expected waste plastic conversion facilities in the European Union, Eastern Europe and Southeast Asia. Continuing our mission to aid in solving the problem of cost-effectively upcycling the vast amount of waste plastic generated on land before it flows into the world's oceans, CS-UK will leverage our patent-pending Plastic Conversion Network ("PCN" to expand its existing portfolio of facilities with the goal to provide sustainable solutions to the global problems posed by plastic pollution. CS-UK will also be vital in Clean Vision becoming recognized as an environmental, social and governance ("ESG" company as CS-UK will act as the custodian for funding raised, if any, through our recently announced Green Bond Offering. Our current expectation is to raise up to $340 million through the Bond Offering.

Under the leadership its Managing Director Shaun Wootton, who also serves as our Executive Director of Asia, CS-UK will leverage its established relationships throughout the Middle East, Southeast Asia, and Europe with the goal of creating a positive environmental impact through strategic project development and investment facilitation. CS-UK, along with our wholly owned subsidiary, Clean-Seas, Inc., will play a pivotal role in advancing the responsible conversion of plastic feedstock into clean fuels and AquaH®, our branded green hydrogen, contributing to the global drive towards plastic circularity while also reducing greenhouse gas emissions.

"I am honored to lead Clean-Seas UK in its mission to drive sustainable development and responsible investment. The establishment of this subsidiary marks a significant step in Clean Vision's commitment to creating positive change on a global scale," said Shaun Wootton.

To strengthen its governance and strategic direction, CS-UK is in the process of assembling a distinguished board anticipated to be comprised of internationally recognized figures in banking, sustainability and energy. Our hope is that a diverse and experienced board will guide CS-UK in realizing its vision of fostering sustainability and environmental stewardship across diverse regions.

Clean Vision continues its mission of driving positive change through innovative and sustainable solutions. The establishment of CS-UK reaffirms the Company's dedication to expanding its global footprint and promoting responsible practices in project development and green finance.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 134

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 364

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 157

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 143

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 204

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 160

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 337

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 169

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 147

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 170

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading

Top 5 Most Recently Viewed Articles

Genmab's Ongoing Share Buy-back Program Details and Impact

Updated Category News Views 119

Introduction to the Share Buy-back Program In a recent announcement, Genmab A/S (NASDAQ: GMAB) revealed that it has initiated an ambitious share buy-back program. This initiative aims to repurchase up to 2.2 million shares, which is a strategic step not just to reduce capital but also to fulfill commitments under the Restricted Stock Unit program. The company anticipates...

Continue Reading
Allego Strengthens Leadership with New Innovative CTO

Updated Category News Views 159

Allego Appoints Holger Riemenschneider as Chief Technology Officer Allego N.V. (NASDAQ: ALGO) has recently appointed Holger Riemenschneider as its Chief Technology Officer. This move is a significant step for the company, which has rapidly established itself as a leading name in the electric vehicle (EV) charging industry. With Holger on board, Allego is looking to...

Continue Reading
Exploring the Growth Drivers of Semiconductor Fabrication Software

Updated Category News Views 167

Understanding the Semiconductor Fabrication Software Market The Semiconductor Fabrication Software market is on the brink of significant transformation, with projections indicating a remarkable growth of approximately USD 984.91 million from 2024 to 2028. This growth is primarily fueled by the rising complexity of semiconductor designs in conjunction with the impact of...

Continue Reading
Ohmyhome Prepares to Share Exciting Q3 2024 Growth Insights

Updated Category News Views 45

Ohmyhome Set to Unveil Q3 2024 Growth Insights As a leading property technology platform, Ohmyhome Ltd. (NASDAQ: OMH) has established itself as a prominent player in the real estate market. The company specializes in offering comprehensive solutions ranging from brokerage, renovation, and management services for properties in the region. As consumers increasingly look for...

Continue Reading
Eli Lilly Prepares for Major Breast Cancer Data Presentation

Updated Category News Views 220

Introduction to Eli Lilly's Breast Cancer Initiatives At the upcoming San Antonio Breast Cancer Symposium (SABCS), Eli Lilly and Company (NYSE: LLY) is set to unveil groundbreaking data that enhances its portfolio in breast oncology. The symposium, running from December 9 to 12, serves as a platform for Lilly to highlight advancements in treatments for hormone...

Continue Reading